Bronchodilators (e.g., Salbutamol, Tiotropium)
Treatment for Silicosis
Typical Dosage: Salbutamol 1-2 puffs q4-6h PRN, Tiotropium 1 inhalation daily
Effectiveness
60%
Safety Score
70%
Clinical Trials
150
Participants
25K
Comparative Safety Scale(Higher is safer)
Cyanide☠️
Meth💀
Cigarettes🚬
Chemo☢️
Alcohol🍺
Morphine💊
Antibiotics💉
Tylenol💊
Exercise🏃
Water💧
70
DangerousModerateSafe
Treatment Details
Dosage Range
Salbutamol 1-2 puffs q4-6h PRN, Tiotropium 1 inhalation daily
Time to Effect
immediate to 2 weeks
Treatment Duration
lifetime
Evidence Quality
HIGHConfidence Score
85%confidence in effectiveness data
Health Economics
Annual Cost of Care
Drug Cost:$300
Monitoring:$150
Side Effect Mgmt:$75
Total Annual:$525
Cost-Effectiveness Analysis
Cost-Effectiveness Rating
GOODQALYs Gained
0.08
Outcome-Based Costs
Cost per Responder
$750
Prescription Access Economics
Annual Societal Loss per Patient
$510
Cost of prescription-only barriers (visits, time, admin, price premium)
Physician Visit Cost
$250/year
Time Cost
$70/year
Travel + wait time
Insurance Admin Cost
$40/year
Prior auth, claims
Rx Price
$300/year
Potential OTC Price
$100/year
Estimated if OTC available
Early Treatment Benefit
+0.02 QALYs
From faster OTC access
Risk Assessment
Misuse Risk
LOWMissed Diagnosis Risk
LOWBronchodilators (e.g., Salbutamol, Tiotropium) Outcomes
for Silicosis
Efficacy Outcomes
Overall Effectiveness
+60%
Response Rate
+70%
Common Side Effects
Tremor
+15%
Dry mouth
+10%
Palpitations
+7%
Sources:
Active Clinical Trials
No active trials currently recruiting for this treatment
No active trials found in ClinicalTrials.gov